MedTech News
.................... by Andrew Celentano

Topical gel helps burn wounds heal faster using an existing FDA-approved drug
Researchers at the Terasaki Institute for Biomedical Innovation and the University of Arizona College of Medicine have developed a topical gel formulation with 4-aminopyridine (4-AP), to treat burn wounds.

CeQur® Announces Exciting Advancements: 2 Recent FDA Clearances and New Clinical Evidence to be Presented at ADA
HORW, Switzerland, June 4, 2026 /PRNewswire/ — CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced two recent FDA clearances for CeQur Simplicity™: extended wear of up to seven days and a new 1-unit (1U) device.

OrthAlign Receives FDA 510(k) Clearance for Lantern ASC Navigation System for Ambulatory Surgery Centers
Irvine, CA-based OrthAlign has announced FDA 510(k) clearance for the Lantern ASC system, a handheld orthopedic navigation solution designed for ambulatory surgery centers. The system pairs a reusable navigation unit with a procedural Smart Pack Kit to deliver accurate, real-time navigation for total knee, partial knee, and gap balancing procedures in both primary and revision cases.

Lab-Grown Brains Could One Day Help Reawaken Nerve Regeneration
Lab-grown brains could help scientists reawaken nerve regeneration.

GE HealthCare earns FDA nod for AI-enabled radiotherapy tech
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software.

University of Glasgow Develops Wireless Implantable Device to Advance Bladder Cancer Therapy
The device, created by engineers and cancer scientists led by Professor David Flynn, represents an important step toward next-generation implantable photonic medical technologies

Immunotherapy added to radiation therapy boosts survival in localized prostate cancer
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer.

AI tool simplifies and scales complete genome assembly, supporting advances in diagnostics and precision medicine
An international research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed HERRO, an artificial intelligence (AI) tool that could make it easier and more cost-effective to produce complete, high-quality genome assemblies.